A comprehensive evaluation of the clinical and cost effectiveness of (multiple) related health technologies (or a single therapy for multiple applications); presented by a drug sponsor after achieving marketing authorisation – for the consideration by a national health agency of whether the costs and benefits of the new treatment warrant its adoption by a national health system programme. A multiple technology appraisal will normally cover more than one technology, or one technology for more than one indication.